Summary of Key Points • Radiation-induced brachial plexopathy (RIBP) occurs with treatment of apical tumors and is frequently complicated by tumor-related brachial plexopathy (TRBP). Stereotactic ablative radiotherapy (SABR) of apical…
Summary of Key Points • Immunotherapy has entered a new era in lung cancer and is rapidly changing the standard of care. • Vaccines as monotherapies have shown marginal efficacy…
Abstract Clinical trials for lung cancer are needed to investigate new treatment or preventative options and to improve outcomes for patients with lung cancer. Times are changing; clinical researchers now…
Summary of Key Points • Development of malignant mesothelioma is usually associated with asbestos exposure. • The most common genetic alterations in mesothelioma are deletion of CDKN2A/ARF , inactivation of…
Abstract This chapter discusses first-line and second-line therapy for patients with extensive-stage small cell lung cancer (ED SCLC). As first-line therapy, a platinum agent plus etoposide or irinotecan remains the…
Summary of Key Points • Lung cancer is increasingly understood at the molecular level; N-of-1 trials are becoming more relevant with the use of biomarker assessment and targeted therapies. •…
Summary of Key Points • The best palliative outcomes are obtained when palliative care is involved early in advanced lung cancer. • Integration of palliative care early in the advanced…
Summary of Key Points † Deceased. • To describe the functions of advocacy. • To describe how lung cancer advocacy groups accomplish their goals. • To describe how they can…
Summary of Key Points • Health services research aims to improve the outcomes to treatment for lung cancer by optimizing the accessibility, quality, and efficiency of treatment programs. • Achieving…
Summary of Key Points • Stereotactic ablative radiotherapy (SABR) is recommended in treatment guidelines as the nonoperative therapy of choice for early-stage nonsmall cell lung cancer (NSCLC). • SABR can…
